Bayesian Capital Management, LP Illumina, Inc. Transaction History

Bayesian Capital Management, LP

$582 Million
Q1 2025

A detailed history of Bayesian Capital Management, LP transactions in Illumina, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 18,400 shares of ILMN stock, worth $1.51 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

18,400

Previous 13,500 36.3%

Holding current value

$1.51 Million

Previous $1.8 Million 19.12%

% of portfolio

0.25%

Previous 0.23%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$79.34 - $144.22 $388,766 - $706,678	4,900 Added 36.3%	18,400 $1.46 Million
Q4 2024 Feb 14, 2025	BUY	$128.99 - $155.15 $812,637 - $977,445	6,300 Added 87.5%	13,500 $1.8 Million
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $758,016 - $978,480	7,200 New	7,200 $938,000
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $1.52 Million - $1.75 Million	-11,900 Reduced 86.86%	1,800 $247,000
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $1.27 Million - $1.95 Million	13,700 New	13,700 $1.91 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $3.65 Million - $4.38 Million	18,820 New	18,820 $4.38 Million
Q1 2019 May 14, 2019	SELL	$272.57 - $321.18 $1.3 Million - $1.54 Million	-4,781 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$272.46 - $366.54 $1.87 Million - $2.52 Million	-6,881 Reduced 59.0%	4,781 $1.43 Million
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $2.09 Million - $2.75 Million	7,500 Added 180.2%	11,662 $4.28 Million
Q2 2018 Aug 14, 2018	BUY	$228.17 - $292.07 $949,643 - $1.22 Million	4,162 New	4,162 $1.16 Million
Q4 2017 Feb 12, 2018	SELL	$202.23 - $230.03 $2.83 Million - $3.22 Million	-14,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $2.41 Million - $3 Million	14,000	14,000 $2.79 Million

Others Institutions Holding ILMN

# of Institutions

847

Shares Held

154M

Call Options Held

1.52M

Put Options Held

1.24M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $12.9B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account

Bayesian Capital Management, LP Illumina, Inc. Transaction History